The money that built these gains is leaving, and there's no guarantee it will return.
In Abuja, Nigeria's health leaders gathered not to celebrate three decades of hard-won progress against HIV, tuberculosis, malaria, and child mortality, but to reckon with its fragility. The global compact that financed much of that progress — wealthy nations investing in poorer ones' health systems — is quietly dissolving as donor budgets shrink on both sides of the Atlantic. What hangs in the balance is not merely funding, but the lives and infrastructure built upon it, now threatened further by climate change, antimicrobial resistance, and the shadow of future pandemics. Nigeria now faces the defining question of whether it can learn to sustain what the world helped it build.
- Decades of life-saving gains — millions of children surviving infancy, HIV transformed from death sentence to chronic condition, malaria pushed back — now rest on a financial foundation that is crumbling beneath them.
- Both Washington and European capitals are cutting health aid budgets, and the withdrawals are accelerating at precisely the moment new threats — climate-driven disease, drug-resistant infections, food insecurity — are multiplying.
- Nigeria's health ministers, past and present, delivered a unified and urgent message at APIN's 25th anniversary: the country can no longer afford to outsource the financing of its own survival.
- APIN's leadership signaled institutional resolve to adapt, but the deeper challenge — building domestic financing mechanisms strong enough to replace vanishing donor support — remains largely unsolved.
- The trajectory is uncertain: whether the next quarter-century continues the arc of progress or slides into retreat will depend on decisions being made, or avoided, right now.
In a conference room in Abuja, Nigeria's health establishment gathered for what was nominally a celebration — the 25th anniversary of APIN Public Health Initiatives — but the mood was more cautionary than festive. The message from the room's most prominent voices was consistent and sobering: the external funding that underwrote Nigeria's public health transformation is receding, and the country must find a way to carry the weight itself.
The achievements being honored are real and hard-won. Since 1990, child mortality has fallen sharply across the developing world through better immunization, improved treatment of pneumonia and diarrhea, and stronger maternal care. Nigeria has vaccinated nearly 17 million girls against cervical cancer. Access to antiretroviral drugs and decentralized treatment centers have turned HIV into a manageable condition. Tuberculosis control has advanced through rapid diagnostics and integration with HIV services. Malaria has been pushed back by bed nets, artemisinin-based drugs, and now vaccines. These gains represent millions of lives — children who survived, mothers who remained.
But the global bargain that made this possible is unraveling. Development assistance from donor nations has begun to shrink — not only from the United States, but increasingly from European governments facing their own fiscal pressures. The timing is particularly dangerous. Climate change is expanding the geographic reach of infectious diseases. Antimicrobial resistance is eroding the tools used to treat them. Economic instability is driving food insecurity, which weakens the immune systems of the most vulnerable. And the risk of future pandemics has never felt more present.
Prof Prosper Okonkwo of APIN spoke with determination, pledging that the organization would adapt. But the larger question — whether Nigeria can build domestic financing mechanisms robust enough to replace what is being lost — remains open. The answer will define whether the next 25 years continue the arc of progress, or mark the beginning of its reversal.
In a conference room in Abuja, Nigeria's health establishment gathered to confront an uncomfortable truth: the money that has underwritten three decades of public health progress is drying up, and there is no guarantee it will return.
The occasion was the 25th anniversary symposium of APIN Public Health Initiatives, but the mood was less celebratory than cautionary. Prof Muhammad Ali Pate, the Coordinating Minister of Health and Social Welfare, sat alongside Prof Isaac Adewole, his predecessor and now Nigeria's ambassador-designate to Canada. Both men, along with APIN's leadership, had come to deliver the same message: Nigeria must learn to fund its own health system, because the world's wealthy nations are pulling back.
Adewole laid out the scale of what is at stake. Since 1990, under-five mortality has plummeted across the developing world—a direct result of better immunization campaigns, smarter treatment of pneumonia and diarrhea, improved nutrition, and stronger maternal care. Nigeria itself has vaccinated nearly 17 million girls against cervical cancer through its HPV vaccine programme. Against HIV, the gains are equally striking: wider access to antiretroviral drugs, decentralized treatment centers, and programs to prevent transmission from mother to child have transformed what was once a death sentence into a manageable chronic condition. Tuberculosis control has been strengthened through the rollout of rapid diagnostic technology and better integration with HIV services. Malaria, once a relentless killer, has been pushed back through insecticide-treated bed nets, artemisinin-based drugs, rapid tests, and now vaccines.
These are not abstract statistics. They represent millions of lives extended, children who survived infancy, mothers who lived to raise their families. The infrastructure that made this possible—the clinics, the supply chains, the trained workers—exists because of a global bargain struck after the Cold War: wealthy nations would help poorer ones build health systems, and in return, the world would be safer from infectious disease.
That bargain is unraveling. Adewole warned that development assistance from donor countries has begun to shrink, and the cuts are no longer confined to Washington. European governments, facing their own fiscal pressures, have also started reducing their health aid budgets. The timing could hardly be worse. Climate change is expanding the range of diseases. Antimicrobial resistance is making infections harder to treat. Economic instability is pushing families into food insecurity, which weakens immunity. And the specter of future pandemics looms larger than ever.
Prof Prosper Okonkwo, the chief executive of APIN, struck a note of determination rather than despair. The organization, he said, would adapt and endure. But his words also carried an implicit acknowledgment: the landscape has shifted in ways few predicted even a few years ago. The question now is whether Nigeria—and countries like it—can build domestic financing mechanisms robust enough to sustain the gains they have fought so hard to achieve. The answer will determine whether the next 25 years look like progress or retreat.
Citações Notáveis
Recent reductions in development assistance by donor countries could undermine decades of progress in public health if countries fail to strengthen domestic financing mechanisms.— Prof Isaac Adewole, former Minister of Health
The global health funding landscape continues to shift in ways that few of us would have predicted a few years ago.— Prof Prosper Okonkwo, CEO of APIN Public Health Initiatives
A Conversa do Hearth Outra perspectiva sobre a história
Why does it matter that donor countries are cutting aid now, specifically? Haven't African health systems always had to be somewhat self-reliant?
The difference is scale and timing. For 25 years, external funding allowed Nigeria to do things it couldn't afford alone—buy vaccines in bulk, train specialists, build supply chains. Now that money is leaving just as new threats are arriving. You can't suddenly switch off a malaria programme and expect the disease not to come roaring back.
But Nigeria is an oil-producing nation. Shouldn't it have been building its own capacity all along?
Yes and no. Oil wealth is volatile and often captured by corruption. The global health system was designed so that wealthy countries would shoulder some of the burden, freeing up domestic resources for other needs. That was the deal. Now the deal is breaking, and countries weren't given much warning.
What happens to the 17 million girls who got the cervical cancer vaccine if the programme stops?
They're protected. But the next cohort of girls won't be. And if you stop vaccinating, immunity in the population drops, and the disease comes back. It's not like you can pause and resume. You have to keep going or lose ground.
Is there any sense that Nigeria could actually replace this funding domestically?
That's the question everyone is asking. It's theoretically possible if the government commits the budget and collects taxes effectively. But it requires political will and sustained investment in a system that doesn't generate immediate returns. It's hard to sell to voters compared to building roads or schools.
So what's the real risk here?
That diseases we thought we'd beaten—malaria, TB, measles—start spreading again. That maternal mortality rises. That a generation of progress simply reverses because the money stopped and nothing replaced it.